SBIR/STTR Research Award

Portable, Hand-Held, High Speed, PCR Thermal Cycler with Real-Time Optical Detection

Award identifier 600da840770e80458cca38c634c0bd6bcc7ffc681b71ccaf0542e9557531ffc3Awarding agency Department of Defense · Army

Award amount

$750,000

Program and phase

SBIR · Phase II

Award year

1998

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Defense
Branch
Army
Recipient company
CEPHEID
Proposal award date
Not reported
Contract end date
Not reported
UEI
W6HQTMWB9Q28
Solicitation number
Not reported
Topic code
Not reported

Research abstract

Cepheid proposes to develop a hand-held, battery-operated, high-speed DNA diagnostic instrument with true real-time, multi-wavelength optical detection and integrated sample purification modules. This instrument will allow practitioners to perform PCR reactions 5-10 times faster than almost all commercial instruments (i.e., 30 PCR cycles in as little as 15 minutes). It will also perform real-time fluorescence detection of up to four separate DNA targets, avoiding post-amplification verification of products (such as electrophoresis) , further decreasing the time of analysis. Phase I will provide the requisite analysis and engineering design for the extension of a previously proven portable prototype thermal cycling instrument into a commercial product. Due to existing interest by third party investors, including diagnostic and life science research product companies, and financial institutions; Cepheid anticipates being able to participate in a Fast Track program. During Phase II, Cepheid will integrate the separate computer controller with the analytical thermal cycling instrument into a single hand-held package, suitable for high volume production. The Phase II product represents a significant step toward Cepheid's vision of a powerful, portable DNA diagnostic instrument capable of receiving raw samples, such as whole blood, extracting and purifying target nucleic acids (DNA and/or RNA), performing amplification, and identifying and quantifying target organisms or sequences. BENEFITS: Instruments based on this approach could be used in biowarfare and medical defense applications, and for rapidly diagnosing diseases (and disease vectors) in the field. Commercial versions will have diverse applications such as identifying infected or contaminated livestock, food, water supplies, and infectious disease diagnostics in the doctor's office or the emergency room. It will lower the cost of such instruments while increasing the speed of analysis.

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Research funding history

5 SBIR/STTR records share this UEI (1998–2006). Reported award amounts total $7,131,244. Reported amounts are not federal obligations.

Phases: Phase II, Phase I

Agencies: Department of Health and Human Services, Department of Defense

Contractor profile

CEPHEID

Historical federal award activity, when published, is on that contractor profile. Matched by UEI only.

Agency intelligence

Department of Defense

NAICS intelligence

This classification comes from the contractor profile, not from the SBIR award record.

Contractor industry classification NAICS 541512

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.